Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Herpes zoster vaccination update : introduction
Filetype[PDF-436.51 KB]


  • Supporting Files:
    No Additional Files
    1. Update on post-licensure safety monitoring of recombinant zoster vaccine (RZV, Shingrix)
      Personal Author:
      Shimabukuro, Tom T.
      Corporate Authors:
      National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Immunization Safety Office.
      Conference Authors:
      United States. Advisory Committee on Immunization Practices. Meeting (2019 February 27-28 : Atlanta, GA)
      Published Date:
      February 28, 2019
      Series:
      ACIP meeting Herpes Zoster Vaccine
      Description:
      Zoster-2-Shimabukuro-508.pdf
      File Type:
      Filetype[PDF - 2.25 MB]
    2. Herpes zoster vaccines: update
      Personal Author:
      Dooling, Kathleen
      Corporate Authors:
      United States. Advisory Committee on Immunization Practices. Herpes Zoster Work Group.
      Conference Authors:
      United States. Advisory Committee on Immunization Practices. Meeting (2019 February 27-28 : Atlanta, GA)
      Published Date:
      February 28, 2019
      Series:
      ACIP meeting Herpes Zoster Vaccine
      Description:
      Zoster-3-Dooling-508.pdf
      File Type:
      Filetype[PDF - 389.16 KB]
You May Also Like:
  1. Herpes Zoster Vaccination update : introduction
    Personal Author:
    Belongia, Edward A.
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices. Zoster Working Group.. Marshfield Clinic Research Institute..
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2018 June 20-21 : Atlanta, GA)
    Published Date:
    8/9/18
    Series:
    ACIP meeting Herpes Zoster Vaccine
    Description:
    Presentations June 2018 Day 1Publication date from document properties.
    File Type:
    Filetype[PDF - 547.59 KB]
  2. Herpes zoster vaccination update : introduction
    Personal Author:
    Moore, Kelly
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices. Hepatitis Vaccines Work Group.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2019 June 26-27, 2019 : Atlanta, GA)
    Published Date:
    June 26, 2019
    Series:
    ACIP meeting Herpes Zoster Vaccine
    File Type:
    Filetype[PDF - 432.52 KB]
  3. Update on recommendations for use of herpes zoster vaccine
    Personal Author:
    Hales, Craig M.; Harpaz, Rafael; Ortega-Sanchez, Ismael; Bialek, Stephanie R.;
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices.. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases..
    Published Date:
    August 22, 2014
    Series:
    MMWR. Morbidity and mortality weekly report, Vol. 63, no. 33, p. 729-31
    Description:
    Herpes zoster vaccine (Zostavax [Merck & Co., Inc.]) was licensed in 2006 and recommended by the Advisory Committee on Immunization Practices (ACIP) in 2008 for prevention of herpes zoster (shingles) and its complications among adults aged ≥60 year...
    Status:
    current
    File Type:
    Filetype[PDF - 195.85 KB]
  4. Herpes Zoster Work Group activity update
    Personal Author:
    Belongia, Edward A.
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices. Herpes Zoster Work Group.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2017 February 22-23 : Atlanta, GA)
    Published Date:
    3/30/17
    Series:
    ACIP meeting Herpes Zoster Vaccine
    Description:
    Presentations February 2017 Day 1On the agenda, this presentation listed as: Introduction.zoster-01-belongia.pdf
    File Type:
    Filetype[PDF - 511.35 KB]
  5. Update on Recommendations for Use of Herpes Zoster Vaccine
    Personal Author:
    Hales, Craig M.; Harpaz, Rafael; Ortega-Sanchez, Ismael; Bialek, Stephanie R.;
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices.
    Published Date:
    Aug 22 2014
    Source:
    MMWR Morb Mortal Wkly Rep. 2014; 63(33):729-731.
    Description:
    Herpes zoster vaccine (Zostavax [Merck & Co., Inc.]) was licensed in 2006 and recommended by the Advisory Committee on Immunization Practices (ACIP) in 2008 for prevention of herpes zoster (shingles) and its complications among adults aged ≥60 year...
    File Type:
    Filetype[PDF - 109.32 KB]